Related Experiment Videos
[Clinical symptoms and laboratory findings in patients with IgA nephropathy (author's transl)]
Nihon Jinzo Gakkai Shi
|September 1, 1981
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Hepatocyte growth factor is linked by O-glycosylated oligosaccharide on the alpha chain.
Biochemical and biophysical research communications·1992
Distribution and possible origins of substance P-containing nerve fibers in the rat liver.
Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft·1992
[Polymorphism of immunoglobulin heavy chain switch region in IgA nephropathy].
Nihon rinsho. Japanese journal of clinical medicine·1992
CD4 subsets in IgA nephropathy.
The Tokai journal of experimental and clinical medicine·1992
Infection of macaque monkeys with a chimeric human and simian immunodeficiency virus.
The Journal of general virology·1992
[A case of renal Fanconi syndrome due to Bence Jones' protein K-type multiple myeloma].
Nihon Jinzo Gakkai shi·2019
[A case of Evans syndrome in a long-term hemodialysis patient].
Nihon Jinzo Gakkai shi·2019
[A case of hemangioma at the left renal papilla of the calix with anemia and gross hematuria].
Nihon Jinzo Gakkai shi·2019
[Uremic toxins and gut micro biome].
Nihon Jinzo Gakkai shi·2019
Genetic background shapes the naïve IgM B cell receptor repertoire in mice.
Frontiers in immunology·2026
Genetically Predicted IgG N-Glycosylation Traits and Risk of Pre-Eclampsia or Eclampsia: A Two-Sample and Multivariable Mendelian Randomization Study.
International journal of women's health·2026
Isolated A1-domain F8 large deletions are associated with favorable immune tolerance induction outcomes in children with severe hemophilia A.
Research and practice in thrombosis and haemostasis·2026
Immune checkpoint inhibitor-induced myocarditis with myositis and/or myasthenia gravis overlap syndrome: A case series.
Experimental and therapeutic medicine·2026
Mesenchymal stem cells: a potential therapeutic strategy for IgA nephropathy.
Frontiers in pharmacology·2026